Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
459
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study

Ghazwa B Korayem1 Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2022-5955View further author information
ORCID Icon,
Omar A Alshaya2 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;3 Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia;4 King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-2244-0491View further author information
ORCID Icon,
Nirvana Alnajjar1 Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi ArabiaView further author information
,
Ahad Alawad1 Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi ArabiaView further author information
,
Rand Alotaibi1 Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi ArabiaView further author information
,
Nader Bin Sheraim5 Pharmaceutical Care Division, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi ArabiaView further author information
,
Fatemah M Hakami6 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0001-6882-9323View further author information
ORCID Icon,
Ohud S Alsudyyes6 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Rahaf H Alsoghayer6 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-8969-6424View further author information
ORCID Icon,
Lina M Alhushan6 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-3319-8271View further author information
ORCID Icon,
Asma H Qudayr6 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;7 Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-1195-0330View further author information
ORCID Icon,
Majed S Al Yami2 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;3 Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia;4 King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaView further author information
&
Omar A Almohammed6 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;8 Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3792-4106View further author information
ORCID Icon show all
Pages 129-140 | Received 06 Oct 2022, Accepted 22 Dec 2022, Published online: 07 Jan 2023

References

  • Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2000;160(6):761. doi:10.1001/archinte.160.6.761
  • Einstein Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499–2510. doi:10.1056/NEJMoa1007903
  • Hokusai-VTE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366(14):1287–1297. doi:10.1056/NEJMoa1113572
  • Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369(15):1406–1415. doi:10.1056/NEJMoa1306638
  • Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799–808. doi:10.1056/NEJMoa1302507
  • Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361(24):2342–2352. doi:10.1056/NEJMoa0906598
  • Haas S, Ageno W, Weitz JI, et al. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐ VTE patients. J Thromb Haemost. 2019;17(10):1694–1706. doi:10.1111/jth.14548
  • Stevens SM, Woller SC, Baumann Kreuziger L, et al. Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160(6):2247–2259. doi:10.1016/j.chest.2021.07.056
  • Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–4738. doi:10.1182/bloodadvances.2020001830
  • Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi:10.1093/eurheartj/ehz405
  • Yeh CH, Gross PL, Weitz JI. Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood. 2014;124(7):1020–1028. doi:10.1182/blood-2014-03-563056
  • Ageno W, Mantovani LG, Haas S, et al. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Lancet Haematol. 2016;3(1):e12–e21. doi:10.1016/S2352-3026(15)00257-4
  • Turpie AGG, Mantovani LG, Haas S, et al. Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study. Thromb Res. 2017;155:23–27. doi:10.1016/j.thromres.2017.04.001
  • Williams M, Ahuja T, Raco V, et al. Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients. J Thromb Thrombolysis. 2022;54(2):219–229. doi:10.1007/s11239-022-02641-5
  • Kuijer PMM, Hutten BA, Prins MH, Büller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 1999;159(5):457. doi:10.1001/archinte.159.5.457
  • Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694. doi:10.1111/j.1538-7836.2005.01204.x
  • Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119–2126. doi:10.1111/jth.13140
  • Burnett AE, Mahan CE, Vazquez SR, Oertel LB, Garcia DA, Ansell J. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb Thrombolysis. 2016;41(1):206–232. doi:10.1007/s11239-015-1310-7
  • Canonico ME, Santoro C, Avvedimento M, et al. Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment. Biomolecules. 2022;12(2):259. doi:10.3390/biom12020259
  • Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica. 2007;92(2):199–205. doi:10.3324/haematol.10516

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.